AVEO Pharmaceuticals Inc. (AVEO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AVEO Pharmaceuticals Inc.

    NASDAQ: AVEO · Real-Time Price · USD
    15.00
    0.00 (0.00%)
    At close: Jan 19, 2023, 10:00 PM

    AVEO Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 38.87M
    Cost of Revenue
    		 4.74M
    Gross Profit
    		 34.14M
    Operating Income
    		 -49.55M
    Interest Income
    		 n/a
    Pretax Income
    		 -53.34M
    Net Income
    		 -61.17M
    Selling & General & Admin
    		 60.81M
    Research & Development
    		 26.3M
    Other Expenses
    		 n/a
    Operating Expenses
    		 87.11M
    Interest Expense
    		 -4.04M
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 91.85M
    Income Tax Expense
    		 7.83M
    Shares Outstanding (Basic)
    		 34.38M
    Shares Outstanding (Diluted)
    		 34.38M
    EPS (Basic)
    		 -1.78
    EPS (Diluted)
    		 -1.78
    EBITDA
    		 -57.39M
    EBIT
    		 -57.39M
    Depreciation & Amortization
    		 -7.83M

    Add to Watchlist